MOLT4细胞
文献支持

MOLT4细胞

收藏
  • ¥1480
  • EK-Bioscience已认证
  • CD-Y1360
  • 2025年07月13日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    MOLT-4/MOLT-4细胞系/MOLT-4细胞株/MOLT-4人急性淋巴细胞白血病

    Cell line name MOLT-4

    Synonyms Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D

    Accession CVCL_0013

    Resource Identification Initiative To cite this cell line use: MOLT-4 (RRID:CVCL_0013)

    Comments Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

    Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: LL-100 blood cancer cell line panel.

    Part of: MD Anderson Cell Lines Project.

    Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.

    Part of: NCI-60 cancer cell line panel.

    Population: Caucasian.

    Doubling time: 31.56 +- 1.49 hours (PubMed=24762992); 33 hours (PubMed=17117183); 29 hours (PubMed=20922763); 24-48 hours (CLS=300115); ~40 hours (DSMZ=ACC-362); 27.9 hours (NCI-DTP=MOLT-4).

    Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).

    Omics: Array-based CGH.

    Omics: CNV analysis.

    Omics: Deep antibody staining analysis.

    Omics: Deep exome analysis.

    Omics: DNA methylation analysis.

    Omics: Deep proteome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: Fluorescence phenotype profiling.

    Omics: lncRNA expression profiling.

    Omics: Metabolome analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.

    Cell type: T-cell; CL=CL_0000084.

    PubMed=3335022

    Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.

    Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

    Cancer Res. 48:589-601(1988)

     

    PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x

    Nakano A., Harada T., Morikawa S., Kato Y.

    Expression of leukocyte common antigen (CD45) on various human leukemia/lymphoma cell lines.

    Acta Pathol. Jpn. 40:107-115(1990)

     

    PubMed=2144611; DOI=10.1128/mcb.10.10.5502-5509.1990; PMCID=PMC361264

    Cheng J., Haas M.

    Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.

    Mol. Cell. Biol. 10:5502-5509(1990)

     

    PubMed=1765142; DOI=10.1016/0014-5793(91)81402-t

    Orita S., Saiga A., Takagi S., Tanaka T., Okumura K., Aono Y., Hinuma Y., Igarashi H.

    A novel alternatively spliced viral mRNA transcribed in cells infected with human T cell leukemia virus type 1 is mainly responsible for expressing p21X protein.

    FEBS Lett. 295:127-134(1991)

     

    PubMed=2041050; DOI=10.1093/jnci/83.11.757

    Monks A., Scudiero D.A., Skehan P., Shoemaker R.H., Paull K.D., Vistica D.T., Hose C.D., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J.G., Boyd M.R.

    Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.

    J. Natl. Cancer Inst. 83:757-766(1991)

     

    CLPUB00447

    Mulivor R.A., Suchy S.F.

    1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.

    (In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992)

     

    PubMed=8316623; DOI=10.2307/3578190

    Evans H.H., Ricanati M., Horng M.-F., Jiang Q.-Y., Mencl J., Olive P.L.

    DNA double-strand break rejoining deficiency in TK6 and other human B-lymphoblast cell lines.

    Radiat. Res. 134:307-315(1993)

     

    PubMed=8127147

    Heyman M., Grander D., Brondum-Nielsen K., Cederblad B., Liu Y., Xu B., Einhorn S.

    Interferon system defects in malignant T-cells.

    Leukemia 8:425-434(1994)

     

    PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x

    Siebert R., Willers C.P., Schramm A., Fossa A., Dresen I.M.G., Uppenkamp M.J., Nowrousian M.R., Seeber S., Opalka B.

    Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.

    Br. J. Haematol. 91:350-354(1995)

     

    DOI=10.11418/jtca1981.15.4_211

    Matsuo Y., Okochi A., Ariyasu T., Iimura E., Ohno T.

    Identification of cell lines with variable numbers of tandem repeat (VNTR) amplified by polymerase chain reaction.

    Tissue Cult. Res. Commun. 15:211-219(1996)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥600
    上海盖宁生物科技有限公司
    2025年09月04日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年06月29日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月14日询价
    ¥1320
    博辉生物科技(广州)有限公司
    2025年11月28日询价
    ¥1350
    镜像绮点(上海)细胞技术有限公司
    2025年12月09日询价
    文献支持
    MOLT4细胞
    ¥1480